Hofseth BioCare ASA reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was NOK 45.89 million compared to NOK 33.61 million a year ago. Revenue was NOK 47.43 million compared to NOK 33.61 million a year ago.

Net loss was NOK 51.89 million compared to NOK 38.01 million a year ago. Basic loss per share from continuing operations was NOK 0.13 compared to NOK 0.1 a year ago. Diluted loss per share from continuing operations was NOK 0.13 compared to NOK 0.1 a year ago.